Extract
Using the radio-iodinated human serum albumin ( [ I I] -RISA) dilution method to measure lamb fetal pulmonary fluid (FPF) volume, we followed the disappearance of proteincomplexed, ' C-labeled phosphatidylcholine ([' C] PC) during the first 90 min after its injection into FPF. The FPF s a m p l e s w e r e a n a l y z e d f o r t o t a l lipid 14C activity and f o r distribution of 14C in PC, other phospholipids (PL), fatty acids (FA), and neutral lipids (NL). For most sampling periods ascending aortic (AAo) and right atrial (RA) blood samples were obtained simultaneously with FPF and serum was analyzed for total lipid 14C activity and for distribution of 14C in total PL, FA, and NL. These studies indicate that (I) PC is cleared rapidly from FPF with an estimated half-time of 15-57 min; (2) FPF-PC may be metabolized to lyso-PC and FA within the fluid itself; and (3) FA derived from FPF-PC enter the pulmonary circulation, thus establishing a pulmonary arteriovenous FA gradient. The possible sites at which PC may be cleared from FPF are considered.
Speculation
The novel possibility is suggested that FPF contains annrnnrint~ en7vmes (nhnsnhnlinasels~~ for deacvlation of PC and also that PC-degradative enzymes are active at the surface of the alveolar epithelial cells. By comparison with results of others regarding the half-life of PC in the air-lung, it appears that PC clearance outside the cell (i.e., after secretion) occupies a relatively short period in the turnover of the molecule. Since the products of PC degradation appear in arterial blood as FA primarily, we may consider FPF as a possible source of serum FA.
Phospholipids, including surface-active phospholipids, are synthesized by the fetal lung and secreted into the FPF (19). With FPF they are expelled periodically from the lung of the lamb fetus and are swallowed (1) . Whether or not they also enter the amniotic fluid compartment and add in a significant way t o its phospholipid content is a moot question which, with regard t o the lamb fetus, has received a negative answer (5). The metabolic fate of FPF phospholipids, of which phosphatidylcholine (PC) is the major component (2, 19) , is not known. Whereas pulmonary PC of adult animals has been shown t o have a half-life of about 12-14 hr (27, 28), the pathway(s) by which PC is degraded or removed from the alveoli have not been determined.
In the present studies, [14C] PC complexed with protein was injected into FPF of lamb fetuses in utero. Simultaneous determinations of FPF volume and volume change by the [ l I] RISA dilution method, as reported in the accompanying paper (25), permitted sequential evaluation of PC clearance in FPF. In addition, we were able to follow incorporation of the 4 C label into other lipids of FPF and its presence in lipids of the blood. These studies show that the half-time of FPF-PC is short and that fatty acids derived from FPF-PC are recovered in the circulation. Possible routes of PC clearance are discussed.
METHODS
Three pregnant ewes (>I35 days gestation) were anesthetized with Na pentobarbital, 15 mg/kg, tracheostomized, and placed o n a ventilator (30) . Anesthesia was maintained with N2 0 : 0 2 7 5 :25 throughout the experiment. Arterial blood was maintained at a Po, of 85-1 10 mm Hg, Pco, of 35-45 mm Hg, and pH of 7.38-7.42.
PREPARATION O F FETUS
The fetuses, three Cfetuses 1, 2, and 3 ) of which were subjects of the experiments reported in the accompanying paper (25), were prepared as described in that report. The fetal trachea was cannulated and catheters were advanced to the ascending aorta (AAo) and right atrium (RA). Fetuses 1 and 2 were twins and fetuses 3 and 4 were singletons. Thus about 50 mg protein and 1 yg [l 4C] PC were added t o FPF. The possible effects of the added protein on FPF osmolality and hydrostatic pressure were discussed in the accompanying report (25), where it was shown that the effect on liquid dynamics during a 90-min period of observation would be negligible. The very small amount of added [ l C ] PC is consonant with its role as a phospholipid tag in these experiments. The significance of the [14C]PC-protein complex is discussed in the final section of the present report.
We found the [ l 4 C ] PC t o be over 98% pure by thin layer chromatography using methods described below. In addition, aliquots of [ l 4C] PC were methylated and the fatty acid esters were quantified by gas-liquid chromatography by methods described previously (24). The percentages of the fatty acid residues of [14C]PC were as follows: Cs:o 18.4%; C14:o 25.0%, C1 6 :o 52.5%; C I 6 : l 3.7%; and C16 :2 or C17 0.4%.
The injectate was mixed with FPF by moving 20 ml between a syringe and the lung at the rate of 20 cycles/min (25). Samples of FPF, 1 .O-3.5 ml, and of blood, 1 .O ml, were obtained at 15, 30, and 45 min Cfetus 3). Additional samples were taken at 3, 60, and 90 min (fetuses 1 and 2 ) and a t 3, 60, and 75 min Cfetus 4).
STABILITY O F ISOTOPES
The stability of RISA in FPF was verified as described previously (25). The stability of protein-complexed [ 1 4 c ] P C in FPF was verified as follows. Aliquots of the original injectate and of the 3-and 90-min FPF samples were separated by polyacrylamide disc gel electrophoresis, 7.0% gel (24). The gels revealed several protein bands (Fig. 1) . The albumin band, the proteins of the separation gel (excluding albumin), and the spacer gel were isolated and prepared for 14c radioisotope survey. (35) . Total lipid extracts from the polyacrylamide disc gels were assayed in the same manner after dissolving the gel in Soluene (36) . Interference from RISA was not expected and this was verified by surveying the lipids for y activity; there was none.
The fractional amount of 14c activity in lipids from TLC was determined and the concentration was obtained by multiplying (fractional ' 4~ activity) by (total lipid ' 4~ activity) per milliliter of sample. The activity in FPF was taken as the product (disintegrations per minute per milliliter) x (Vs). For those samples of FPF that were obtained before homogeneous distribution of RISA (e.g., at 3 min), FPF activity was determined by assuming that the distribution of both RISA and [' 4~] PC-protein was essentially the same.
IN VITRO EXPERIMENTS
The FPF was taken from a full term fetus which had not been used in prior experimentation. The FPF was divided into aliquots of 2.0 ml to which 0.1 25 yCi [' C] PC (3 1) and Tris buffer were added. Quadruplicate tubes were brzught to pH 6, 7, and 8, respectively, and incubated at 37 for 9 0 min. Samples were taken at 3 and 90 min and extracted in CHC13 :CH30H, to which was added 98 yg PC from a standard mixture (32) of PC, phosphatidylethanolamine, ly solecithin, and cholesterol, and then separated o n TLC. The standard mixture was used to facilitate identification and recovery of lipids from the TLC plates. Aliquots of total lipid extract and of individual lipids from TLC were surveyed for radioactivity as described.
RESULTS
The distribution of 14c within the separation and spacer gels after disc electrophoresis of the original injectate (.RISA + [' 4~] PC-protein) was 45% in the albumin band, 36% in the other proteins of the separation gel, and 19% in the spacer gel.
The distribution of the ' 4~ that remained in FPF after 3 and 90 min was 45% in albumin, 47% in other proteins of the separation gel, and 8% in the spacer gel. The electrophoretic migration of proteins is shown in Figure 1 .
The decrease in FPF 1 4 c -p c radioactivity with time is presented in Figure 2 as is the decrease of 1 4 C activity in the total lipids of FPF. Two slopes are apparent from inspection of the mean disintegration,^ per minute-time plot ( Of the total radioactivity in the lipids of FPF about 90% (80%-95%) was recovered in PC, about 7% was in phospholipids other than PC (including lyso-PC, sphingomyelin, and phosphatidylethanoiamine), about 1 .O% was recovered in cholesterol, cholesteryl esters, tri-and diglycerides, and about 3% in free fatty acids ( Table 1) .
The results of the in vitro experiments are given in Figure 3 . After 9 0 rnin incubation at 37O, 92-95% of the 14c activity at 3 min was still in PC, 5%-8% of the activity was recovered in lyso-PC and fatty acids, and total 14c activity was The recovery of ' C activity in serum and its distribution among serum lipids is summarized in Figure 4 . The radioiso- Fig. 1 . Polyacrylamide gel electrophoresis. Left: the proteins to tope was Present in each AAo and RA sample including those which 14C-labeled phosphatidylcholine was complexed in injectate taken 3 min after [' CI PC had been injected into FPF. Fatty (see Reference 31) . Albumin contained 45% of the C activity; the acids (FA) accounted for most of the ' 4~ activity of arterial other proteins contained 36%; 19% was in the spacer gel (not shown).
(AAo) serum: thus, [ l 4 c ] FA made UP 71-91% ( m a n = 80%) Right: fetal pulmonary fluid proteins 90 min after administration of of the total activity of the lipids. Conversely, the proportional injectate in vivo. Protein disQibution is similar to that of injectate, content of [ I 4 Cl FA in RA serum was generally lower and except for two additional bands in the postalbumin region. The l 4 C showed greater variation, 1 5~8 8 % (mean = 46%), than that of distribution was 45% in albumin, 47% in other proteins, and 8% in AAo serum. In 15 of 17 paired samples there was an AAo t o spacer gel (not shown). Interestingly, protein distribution in crude FPF RA gradient for [ ' C] FA; in two paired samples [ ' CI FA (i.e., without injectate) resembles that shown on the right (see activity was slightly higher in RA serum. The distribution of Reference 19). 14c within other lipids of AAo serum was generally greater in phospholipids (including PC, phosphatidylethanolamine, FPF contains the same surface-active phospholipids that are sphingomyelin, and lyso-PC) than in neutral lipids (including found in pulmonary washings which presumably sample the cholesterol, cholesteryl esters, and tri-and diglycerides). The alveolar surface; these lipids are products of alveolar epithelial same was true for RA serum except in the case of Fetus 1 cell synthesis and secretion; and they presumably help t o where most of the isotope was present in neutral lipids.
establish the alveolar lining layer of the air-lung at birth (2, 1 1, 20, 21). The FPF offers the advantage of direct sampling from the natural state, whereas sampling of the alveolar lining layer DISCUSSION introduces a number of problems including contamination from other pulmonary sources (22, 24). Pulmonary phospholipids, predominantly disaturated PC, are synthesized in the lung and secreted into the alveolar space PC-PROTEIN COMPLEX (8, 27, 28), where they help form and maintain the alveolar lining layer of the air-breathing mammal. The remarkable As expected, both the "albumin" (31) that was used t o rapidity of this process was demonstrated by the observation complex [ 1 4 c ] PC and the FPF contained other, slower-movof Darrah and Hedley-Whyte (8) that 43% of the radioactivity ing proteins (References 19, 24, and Fig. 1 ) with which 47% of in the lung was present in PC 1 rnin after radiolabeled the [ ' C] PC was associated after electrophoresis of FPF. In palmitate was injected into the circulation. We have shown addition, 45% of the [' C] PC of FPF migrated with albumin that serum [14c]palmitate precursor is also rapidly metabo-in the disc gels. Thus we may conclude that over 90% of the lized in the lamb fetus and that the label appears in [ 1 4 c ] PC tag was complexed with protein in the FPF of the phospholipids of FPF within 15 rnin after intravenous present studies. administration (19). For the air-lung the biologic half-time of Migration of [ 1 4 c ] p c with protein into the disc gels is of pulmonary PC is 12-14 hr (27, 28), and the estimated interest, since previous studies of the air-lung of adult animals half-time of PC of the alveolar lining layer (alveolar PC) is 17.5 showed that more than 90% of the phospholipids in hr (27). Analogous data, however, are not available for the pulmonary washings, derived presumably from the alveolar fetus and FPF, and little is known about the degradation and lining layer as the primary source, do not enter the disposal of alveolar PC in general.
polyacrylamide gel (23, 24). Thus the PC-protein complexes We feel that FPF is an excellent source for the study of that were produced in the laboratory (i.e., in the injectate, alveolar PC and, in addition, that extrapolations may be made where the protein t o PC ratio and protein concentration were t o the alveolar lining layer of the air-lung for several reasons: much higher than in pulmonary washings (24)) are more stable than those derived from pulmonary lavage, in so far as they persist in the electrophoretic field and during migration through the gel. In addition, although the number of complexes may be increased, they are otherwise unchanged when the injectate is mixed with FPF. In the accompanying paper (25), we indicated that RISA diffuses rapidly and homogeneously within FPF and that there is n o direct transfer of RISA out of the FPF compartment during the period of study. We also indicated that the primary barrier t o direct transfer of RISA out of FPF was the lumenal surface of epithelial cells (25). Therefore, if the [14C] PC-protein complexes of the present study had retained diffusion and permeability characteristics similar t o those of RISA in FPF, we may assume that [ Since our assay in these experiments was the ' 4~ activity in lipids of FPF that was sampled from the trachea, our comments will be restricted t o the clearance of [ 1 4 c ] P C from the bulk liquid phase of FPF. From this perspective it is apparent that [' 4~] PC is cleared rapidly. The slope, [' C] PC ddpmldt, gives a half-time of about 15 min between 3 and 3 0 min, and a half-time of about 57 min between 30 and 9 0 min. These times are extremely rapid when compared with the biologic half-time of 17.5 hr for "alveolar" PC (27). The latter includes the process of transfer of palmitate precursor from blood t o epithelial cell, incorporation of palmitate into PC during biosynthesis, secretion of PC into the alveolar space, and degradation and removal of PC from the alveolus. If these studies of pulmonary PC of the air-lung may be compared with our findings on FPF-PC, it appears that clearance of extracellular PC in the bulk liquid phase of FPF is a short interval in the total life of the molecule.
From our studies of Vs and Ve (25), it is apparent that only about 5% of total F P F can leave the lung per hour without a net depletion of FPF volume. This relatively slow flow, coupled with rapid clearance of PC in siru, suggests that pulmonary PC can make only a small contribution t o the PC content of amniotic fluid. The additional observations that PC is degraded rapidly in amniotic fluid itself (18), that other, nonpulmonary, sources account for phospholipids in amniotic fluid (5), and that it is quite problematic that FPF is expectorated by the lamb into amniotic fluid in the first place ( I ) , indicate that further study is needed before categorical acceptance of the lung as a major or exclusive source of amniotic fluid phospholipids (4, 14) .
There are several possibilities regarding the site at which PC of bulk FPF is cleared: the first is FPF itself. Our in vitro experiments (Fig. 3 ) indicate that degradative processes within FPF could account for less than 10% of the total breakdown of [ 1 4 c ] PC. Since the I4c is recovered in fatty acids and lyso-PC of FPF, the possibility presents itself that phospholipase(s) may be active within FPF. The presence of phospholipase A in pulmonary tissue of adult rats has been demonstrated (13), but t o our knowledge the possibility of extracellular pulmonary deacylation has not been reported heretofore. As noted above, degradation (not further specified) of PC also takes place rapidly in amniotic fluid (18), but through incorporation into pulmonary macrophages. This has been suggested as a mechanism for removal of components of the surfactant system in the alveolar lining layer of the air-lung (20, 29). Although the mechanism may be valid ex utero, it is probably insignificant in the fetus because of the sparcity of pulmonary macrophages during gestation (1 6). However, since we made n o attempt t o recover macrophages in our experiments we cannot speculate further. A third possibility presents itself from the observation that over 90% of the known that reactions involving lipid substrates often proceed at significant rates only when a definite lipid-water interface is formed ( l o ) , e.g., FPF-PC at the plasma membrane, rather than in an aqueous environment where the substrate may be present as small loose aggregations of a few molecules only, e.g., FPF-PC in FPF. If initial clearance of protein-complexed PC does take place at the epithelial surface, we may speculate that the products of subsequent degradation, including fatty acids, could gain access t o the cell o r interstitium o r be transferred directly t o the circulation (3, 12) . Our observations that l 4 C-labeled fatty acids predominate in arterial blood and that there is a marked increase from venous t o arterial blood (Fig. 4 ) are in accord with this scheme (Fig. 5) . The identification of phospholipase A l activity in plasma membranes of rat liver cells by Newkirk and Waite (17) lends additional support by analogy. . l u n g o f t h e a d u l t h u m a n , b u t t h a t n e t t r a n s f e r o f triglycerides 21. Scarpelli, E. M., Agasso, E. J., and Kikkawa, Y.: Demonstration of and c h o l e s t e r o l is variable. From the p r e s e n t d a t a we cannot the significance of pulmonary surfactants at birth. Resp. Physiol., 12: 110 (1971). b e m o r e specific c o n c e r n i n g n e u t r a l lipids s i n c e they were not 22. Scarpelli lyso-PC a n d f a t t y acid w i t h i n FPF itself. I t is also suggested 27. Thomas, T., Jr., and Rhoades, R.
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